{"title":"欧洲心脏病学学会亮点:最新科学MINOCA/ANOCA。","authors":"Peter Ong, Andreas Seitz","doi":"10.15420/ecr.2022.22","DOIUrl":null,"url":null,"abstract":"increase without percutaneous coronary intervention. During a mean follow-up of 3.4 ± 3.6 years, 3,321 deaths occurred (18.2%). Compared to patients without MI (16.1%), patients with type 1 MI (25.2%) and type 2 MI (29.1%) had significantly higher mortality rates (p<0.001). Kaplan–Meier analysis confirmed the lowest survival rates occurred in patients with type 2 MI. 2 Moreover, Barrett et al. showed that 1,544 MINOCA patients from Israel had a favourable short-term outcome but their long-term outcome was comparable to that of patients with acute MI due to obstructive coronary artery disease. 3 In addition, in a study including 712 Spanish patients with acute coronary syndrome (ACS), Espinosa Pascual et al. highlighted that pro-inflammatory states such as autoimmune pathologies, connective tissue disease, active cancer and infections should be regarded as risk factors for the occurrence of MINOCA. 4","PeriodicalId":45957,"journal":{"name":"European Cardiology Review","volume":"17 ","pages":"e18"},"PeriodicalIF":3.2000,"publicationDate":"2022-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/c3/61/ecr-17-e18.PMC9819995.pdf","citationCount":"0","resultStr":"{\"title\":\"European Society of Cardiology Highlights: Late-breaking Science MINOCA/ANOCA.\",\"authors\":\"Peter Ong, Andreas Seitz\",\"doi\":\"10.15420/ecr.2022.22\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"increase without percutaneous coronary intervention. During a mean follow-up of 3.4 ± 3.6 years, 3,321 deaths occurred (18.2%). Compared to patients without MI (16.1%), patients with type 1 MI (25.2%) and type 2 MI (29.1%) had significantly higher mortality rates (p<0.001). Kaplan–Meier analysis confirmed the lowest survival rates occurred in patients with type 2 MI. 2 Moreover, Barrett et al. showed that 1,544 MINOCA patients from Israel had a favourable short-term outcome but their long-term outcome was comparable to that of patients with acute MI due to obstructive coronary artery disease. 3 In addition, in a study including 712 Spanish patients with acute coronary syndrome (ACS), Espinosa Pascual et al. highlighted that pro-inflammatory states such as autoimmune pathologies, connective tissue disease, active cancer and infections should be regarded as risk factors for the occurrence of MINOCA. 4\",\"PeriodicalId\":45957,\"journal\":{\"name\":\"European Cardiology Review\",\"volume\":\"17 \",\"pages\":\"e18\"},\"PeriodicalIF\":3.2000,\"publicationDate\":\"2022-09-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/c3/61/ecr-17-e18.PMC9819995.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"European Cardiology Review\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.15420/ecr.2022.22\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2022/2/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q2\",\"JCRName\":\"CARDIAC & CARDIOVASCULAR SYSTEMS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Cardiology Review","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.15420/ecr.2022.22","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/2/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
European Society of Cardiology Highlights: Late-breaking Science MINOCA/ANOCA.
increase without percutaneous coronary intervention. During a mean follow-up of 3.4 ± 3.6 years, 3,321 deaths occurred (18.2%). Compared to patients without MI (16.1%), patients with type 1 MI (25.2%) and type 2 MI (29.1%) had significantly higher mortality rates (p<0.001). Kaplan–Meier analysis confirmed the lowest survival rates occurred in patients with type 2 MI. 2 Moreover, Barrett et al. showed that 1,544 MINOCA patients from Israel had a favourable short-term outcome but their long-term outcome was comparable to that of patients with acute MI due to obstructive coronary artery disease. 3 In addition, in a study including 712 Spanish patients with acute coronary syndrome (ACS), Espinosa Pascual et al. highlighted that pro-inflammatory states such as autoimmune pathologies, connective tissue disease, active cancer and infections should be regarded as risk factors for the occurrence of MINOCA. 4